Terms: = Liver cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
278 results:
1. Immune regulation and therapeutic application of T regulatory cells in liver diseases.
Ajith A; Merimi M; Arki MK; Hossein-Khannazer N; Najar M; Vosough M; Sokal EM; Najimi M
Front Immunol; 2024; 15():1371089. PubMed ID: 38571964
[TBL] [Abstract] [Full Text] [Related]
2. Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles.
Hsu CY; Mustafa MA; Kumar A; Pramanik A; Sharma R; Mohammed F; Jawad IA; Mohammed IJ; Alshahrani MY; Ali Khalil NAM; Shnishil AT; Abosaoda MK
Pathol Res Pract; 2024 Apr; 256():155266. PubMed ID: 38554489
[TBL] [Abstract] [Full Text] [Related]
3. Multiple Immunomodulatory Strategies Based on Targeted Regulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Immune Homeostasis against Hepatocellular Carcinoma.
Fang S; Zheng L; Shu GF; Xiaoxiao C; Guo X; Ding Y; Yang W; Chen J; Zhao Z; Tu J; Chen M; Ji JS
ACS Nano; 2024 Mar; 18(12):8811-8826. PubMed ID: 38466366
[TBL] [Abstract] [Full Text] [Related]
4. Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases.
Chen Q; Deng Y; Li Y; Chen J; Zhang R; Yang L; Guo R; Xing B; Ding P; Cai J; Zhao H
Cancer Lett; 2024 Apr; 588():216778. PubMed ID: 38458593
[TBL] [Abstract] [Full Text] [Related]
5. Evaluating CD4 and foxp3 mRNA Expression in Tissue Specimens of Celiac Disease and Colorectal cancer Patients.
Asri N; Nazemalhosseini Mojarad E; Taleghani MY; Houri H; Saeedi Niasar M; Rezaei-Tavirani M; Jahani-Sherafat S; Shahbazkhani A; Nikzamir A; Ehsani Ardakani MJ; Khodadost M; Rostami-Nejad M
Asian Pac J Cancer Prev; 2024 Feb; 25(2):647-652. PubMed ID: 38415552
[TBL] [Abstract] [Full Text] [Related]
6. Characterization of lymphocyte-rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures.
Ahn B; Ahn HS; Shin J; Jun E; Koh EY; Ryu YM; Kim SY; Sung CO; Shim JH; Hong J; Kim K; Kang HJ
Liver Int; 2024 May; 44(5):1202-1218. PubMed ID: 38363048
[TBL] [Abstract] [Full Text] [Related]
7. The 'Other' subfamily of HECT E3 ubiquitin ligases evaluate the tumour immune microenvironment and prognosis in patients with hepatocellular carcinoma.
Dong R; Wang Z; Cao D; Li Y; Fei Y; Gao P; Zhu M; Chen Z; Cai J; Zuo X
IET Syst Biol; 2024 Feb; 18(1):23-39. PubMed ID: 38318939
[TBL] [Abstract] [Full Text] [Related]
8. FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer.
Li H; Zheng N; Guo A; Tang W; Li M; Cao Y; Ma X; Cao H; Ma Y; Wang H; Zhao S
Cell Death Dis; 2024 Feb; 15(2):107. PubMed ID: 38302412
[TBL] [Abstract] [Full Text] [Related]
9. Beyond foxp3: a 20-year journey unravelling human regulatory T-cell heterogeneity.
Santosh Nirmala S; Kayani K; Gliwiński M; Hu Y; Iwaszkiewicz-Grześ D; Piotrowska-Mieczkowska M; Sakowska J; Tomaszewicz M; Marín Morales JM; Lakshmi K; Marek-Trzonkowska NM; Trzonkowski P; Oo YH; Fuchs A
Front Immunol; 2023; 14():1321228. PubMed ID: 38283365
[TBL] [Abstract] [Full Text] [Related]
10. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
[TBL] [Abstract] [Full Text] [Related]
12. IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction.
Shiri AM; Zhang T; Bedke T; Zazara DE; Zhao L; Lücke J; Sabihi M; Fazio A; Zhang S; Tauriello DVF; Batlle E; Steglich B; Kempski J; Agalioti T; Nawrocki M; Xu Y; Riecken K; Liebold I; Brockmann L; Konczalla L; Bosurgi L; Mercanoglu B; Seeger P; Küsters N; Lykoudis PM; Heumann A; Arck PC; Fehse B; Busch P; Grotelüschen R; Mann O; Izbicki JR; Hackert T; Flavell RA; Gagliani N; Giannou AD; Huber S
J Hepatol; 2024 Apr; 80(4):634-644. PubMed ID: 38160941
[TBL] [Abstract] [Full Text] [Related]
13. Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.
Hamed A; Ghareeb D; Mohamed TM; Hamed M; Nofal MS; Gaber M
BMC Complement Med Ther; 2023 Oct; 23(1):384. PubMed ID: 37891562
[TBL] [Abstract] [Full Text] [Related]
14. Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma.
Suzuki H; Iwamoto H; Tanaka T; Sakaue T; Imamura Y; Masuda A; Nakamura T; Koga H; Hoshida Y; Kawaguchi T
Hepatol Int; 2024 Apr; 18(2):610-622. PubMed ID: 37864726
[TBL] [Abstract] [Full Text] [Related]
15. Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.
He X; Peng Y; He G; Ye H; Liu L; Zhou Q; Shi J; Fu S; Wang J; Zhou Z; Li W
J Transl Med; 2023 Oct; 21(1):717. PubMed ID: 37828574
[TBL] [Abstract] [Full Text] [Related]
16. Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients.
Zamani F; Khalighfard S; Kalhori MR; Poorkhani A; Amiriani T; Hosseinzadeh P; Esmati E; Alemrajabi M; Nikoofar A; Safarnezhad Tameshkel F; Alizadeh AM
Med Oncol; 2023 Sep; 40(10):302. PubMed ID: 37725175
[TBL] [Abstract] [Full Text] [Related]
17. TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas.
Giannikou K; Klonowska K; Tsuji J; Wu S; Zhu Z; Probst CK; Kao KZ; Wu CL; Rodig S; Marino-Enriquez A; Zen Y; Schaefer IM; Kwiatkowski DJ
Histopathology; 2023 Oct; 83(4):569-581. PubMed ID: 37679051
[TBL] [Abstract] [Full Text] [Related]
18. Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis.
Zhang S; Fang W; Zhou S; Zhu D; Chen R; Gao X; Li Z; Fu Y; Zhang Y; Yang F; Zhao J; Wu H; Wang P; Shen Y; Shen S; Xu G; Wang L; Yan C; Zou X; Chen D; Lv Y
Nat Commun; 2023 Aug; 14(1):5123. PubMed ID: 37612267
[TBL] [Abstract] [Full Text] [Related]
19. HBx promotes hepatocellular carcinoma progression by repressing the transcription level of miR-187-5p.
Deng Y; Wang L; Zhang Y; Sun D; Min H; Zhou H; Xu C; Xu N; Qiu F; Zhou J; Zhou J
Aging (Albany NY); 2023 Aug; 15(15):7533-7550. PubMed ID: 37531206
[TBL] [Abstract] [Full Text] [Related]
20. Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.
Mariani P; Torossian N; van Laere S; Vermeulen P; de Koning L; Roman-Roman S; Lantz O; Rodrigues M; Stern MH; Gardrat S; Lesage L; Champenois G; Nicolas A; Matet A; Cassoux N; Servois V; Romano E; Piperno-Neumann S; Lugassy C; Barnhill R
Br J Cancer; 2023 Sep; 129(5):772-781. PubMed ID: 37443346
[TBL] [Abstract] [Full Text] [Related]
[Next]
